| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/BIP.23031 |
| P698 | PubMed publication ID | 28555756 |
| P50 | author | Dawid Debowski | Q56550116 |
| Krzysztof Rolka | Q58147469 | ||
| Anna Łęgowska | Q60633041 | ||
| Agata Gitlin-Domagalska | Q88178581 | ||
| P2093 | author name string | Michael Gütschow | |
| Marit Stirnberg | |||
| Joanna Okońska | |||
| P2860 | cites work | Sunflower trypsin inhibitor 1 as a molecular scaffold for drug discovery | Q37971976 |
| Twenty years of the MEROPS database of proteolytic enzymes, their substrates and inhibitors. | Q38400921 | ||
| Spliced analogues of trypsin inhibitor SFTI-1 and their application for tracing proteolysis and delivery of cargos inside the cells | Q38746354 | ||
| Identification of the First Low-Molecular-Weight Inhibitors of Matriptase-2 | Q39671578 | ||
| Sunflower trypsin inhibitor 1 derivatives as molecular scaffolds for the development of novel peptidic radiopharmaceuticals | Q39770968 | ||
| Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation | Q39986548 | ||
| Matriptase activates stromelysin (MMP-3) and promotes tumor growth and angiogenesis | Q40227949 | ||
| High-affinity cyclic peptide matriptase inhibitors | Q40601659 | ||
| Implication of the disulfide bridge in trypsin inhibitor SFTI-1 in its interaction with serine proteinases. | Q42841595 | ||
| Two-step selective formation of three disulfide bridges in the synthesis of the C-terminal epidermal growth factor-like domain in human blood coagulation factor IX | Q42844329 | ||
| Loss of the matriptase inhibitor HAI‐2 during prostate cancer progression | Q42945644 | ||
| Synthesis and evaluation of the sunflower derived trypsin inhibitor as a potent inhibitor of the type II transmembrane serine protease, matriptase. | Q43732256 | ||
| Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis | Q44007860 | ||
| Between two worlds: a comparative study on in vitro and in silico inhibition of trypsin and matriptase by redox-stable SFTI-1 variants at near physiological pH. | Q45741340 | ||
| Analogues of trypsin inhibitor SFTI-1 modified in the conserved P₁' position by synthetic or non-proteinogenic amino acids retain their inhibitory activity | Q45794145 | ||
| Examples of peptide-peptoid hybrid serine protease inhibitors based on the trypsin inhibitor SFTI-1 with complete protease resistance at the P1-P1' reactive site | Q46482047 | ||
| Abbreviated nomenclature for cyclic and branched homo- and hetero-detic peptides. | Q46483032 | ||
| Membrane-bound serine protease matriptase-2 (Tmprss6) is an essential regulator of iron homeostasis | Q46560159 | ||
| Matriptase inhibition by hepatocyte growth factor activator inhibitor-1 is essential for placental development | Q52573669 | ||
| Engineering pro-angiogenic peptides using stable, disulfide-rich cyclic scaffolds | Q59286580 | ||
| Ovarian carcinoma subtypes are different diseases: implications for biomarker studies | Q21563402 | ||
| Matriptase-2, a membrane-bound mosaic serine proteinase predominantly expressed in human liver and showing degrading activity against extracellular matrix proteins | Q24302437 | ||
| Regulation of cell surface protease matriptase by HAI2 is essential for placental development, neural tube closure and embryonic survival in mice | Q24313255 | ||
| Molecular mechanisms of the defective hepcidin inhibition in TMPRSS6 mutations associated with iron-refractory iron deficiency anemia | Q24314377 | ||
| High-resolution structure of a potent, cyclic proteinase inhibitor from sunflower seeds | Q27618903 | ||
| Structure of a proteolytically resistant analogue of (NLys)5SFTI-1 in complex with trypsin: evidence for the direct participation of the Ser214 carbonyl group in serine protease-mediated proteolysis | Q27689437 | ||
| Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction | Q27860958 | ||
| Matriptase-2 inhibits breast tumor growth and invasion and correlates with favorable prognosis for breast cancer patients | Q28306692 | ||
| PyBOP®: A new peptide coupling reagent devoid of toxic by-product | Q29303117 | ||
| Kinetics of the reversible inhibition of enzyme-catalysed reactions by tight-binding inhibitors | Q29617995 | ||
| Matriptase, HAT, and TMPRSS2 activate the hemagglutinin of H9N2 influenza A viruses | Q30424187 | ||
| Matriptase proteolytically activates influenza virus and promotes multicycle replication in the human airway epithelium | Q30426551 | ||
| Molecular recognition mechanisms of thrombin | Q33221756 | ||
| Role of matriptase-2 (TMPRSS6) in iron metabolism | Q33792112 | ||
| Down-regulation of Bmp/Smad signaling by Tmprss6 is required for maintenance of systemic iron homeostasis | Q33834771 | ||
| Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation | Q33917709 | ||
| The interaction of thrombin with fibrinogen. A structural basis for its specificity | Q34416186 | ||
| Substrate specificity of human matriptase-2. | Q35026724 | ||
| Improving the Selectivity of Engineered Protease Inhibitors: Optimizing the P2 Prime Residue Using a Versatile Cyclic Peptide Library | Q35783014 | ||
| Cleavage activation of the human-adapted influenza virus subtypes by matriptase reveals both subtype and strain specificities | Q36276614 | ||
| Reducing TMPRSS6 ameliorates hemochromatosis and β-thalassemia in mice | Q36733512 | ||
| An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe(-/-) mice and ameliorates anemia and iron overload in murine β-thalassemia intermedia | Q36849024 | ||
| Exosites in the substrate specificity of blood coagulation reactions | Q36884329 | ||
| Type II transmembrane serine proteases in development and disease | Q37055730 | ||
| IC50-to-Ki: a web-based tool for converting IC50 to Ki values for inhibitors of enzyme activity and ligand binding | Q37245607 | ||
| Matriptase: a culprit in cancer? | Q37401353 | ||
| Matriptase-2 (TMPRSS6): a proteolytic regulator of iron homeostasis | Q37450622 | ||
| Iron-refractory iron deficiency anemia: new molecular mechanisms. | Q37602503 | ||
| Peptoid-Peptide hybrid backbone architectures. | Q37657397 | ||
| P433 | issue | 6 | |
| P577 | publication date | 2017-11-01 | |
| P1433 | published in | Biopolymers | Q15767528 |
| P1476 | title | Design and chemical syntheses of potent matriptase-2 inhibitors based on trypsin inhibitor SFTI-1 isolated from sunflower seeds | |
| P478 | volume | 108 |
| Q93015323 | Antibodies raised against a Sunn bug (Eurygaster integriceps Put.) recombinant protease, rGHP3p2, can inhibit gluten-hydrolyzing activity | cites work | P2860 |
Search more.